Clinical safety: Do not abruptly discontinue benzodiazepines in a patient who may be physically dependent except where exceptional medical circumstances require it.

FOR HEALTHCARE PROFESSIONALS

Treat discontinuation as a clinical process—not a handoff.

Concise implementation principles and links to the current source guidance. This page does not replace clinical judgment or the full guideline.

Core practice principles

1. Assess

Review indication, medication history, duration, dose and formulation, co-prescribed substances, prior withdrawal experience, comorbidities, pregnancy status when relevant, seizure risk, fall risk, and patient goals.

2. Engage

Use shared decision-making. Explain physical dependence without conflating it with addiction. Discuss risks, benefits, uncertainty, preferences, and the patient’s previous experience.

3. Individualize

No schedule is suitable for every patient. The ASAM guideline describes a typical initial pace of 5–10% reductions every 2–4 weeks and generally not more than 25% every two weeks, while emphasizing slower or paused reductions when clinically indicated. Consult the full guideline before applying recommendations.

4. Monitor and adjust

Follow symptoms, functioning, underlying conditions, and safety. Build in a clear method for contacting the care team. Do not frame adjustment or pausing as failure.

5. Continue care

Preserve treatment for the original condition, coordinate across prescribers and pharmacists, and ensure appropriate support before, during, and after discontinuation.

Language matters. Document “physical dependence” when that is what is meant. Avoid stigmatizing patients whose prescribed use has led to physiological adaptation.

Implementation checklist

Primary clinical resources

Scope note: BenzoHelp does not certify clinicians or endorse individual providers. Materials should be locally reviewed before being incorporated into clinical policy.